Skip to main content

RHUMBLINE ADVISERS

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1115418 BOSTON, MA

Position in ZNTL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$270,436
+$136,015 QoQ
Shares Held
55,760
-34.0% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 114 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 17% Shared 0% None 83%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. ZNTL ranks #223 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ZNTL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $270,436 55,760
2025-03-31 $134,421 84,542
2024-12-31 $279,408 92,214
2024-09-30 $319,103 86,713
2024-06-30 $385,331 94,213
2024-03-31 $1,304,329 82,762
2023-12-31 $1,224,120 80,800
2023-09-30 $1,622,252 80,870
2023-06-30 $1,884,428 66,800
2023-03-31 $1,112,960 64,707
2022-12-31 $1,167,656 57,977
2022-09-30 $1,188,202 54,857
2022-06-30 $1,283,720 45,684
2022-03-31 $1,749,767 37,923
2021-12-31 $2,979,758 35,448
2021-09-30 $2,310,142 34,666
2021-06-30 $1,696,548 31,890
2021-03-31 $1,328,124 30,609
2020-12-31 $1,685,816 32,457
2020-09-30 $395,875 12,110
2020-06-30 $631,030 13,141